Pre-exposure prophylaxis, more commonly referred to as PrEP, is an anti-retroviral drug taken by HIV-negative people which, if used consistently, can help to dramatically reduce the risk of acquiring the virus.
On 30 June, Welsh health minister Vaughan Gething announced that it will be made routinely available to citizens on the NHS.
The news comes three years after the PrEPARD study, in which 1,200 people were prescribed the drug. “There have been no new diagnoses of HIV amongst people taking PrEP in Wales,” he said in a statement. “We have also benefited from the emergence of generic versions of PrEP that are available to the NHS at a greatly reduced price when compared to the proprietary product. “This, together with the interim data